Lipid metabolism involves a wide range of processes in which lipids are processed and used as energy sources, signaling molecules and structural elements of cells. Given its importance, dysfunctions in lipid metabolism, both small and large, can have significant negative effects for the body. In line, there is a wide range of lipid disorders and diseases which increase the risk of developing fatal diseases such as liver and cardiovascular disease and cancer. Importantly, due to the rise of the so-called Western lifestyle, characterized by excessive caloric consumption and low energy expenditure, an alarming and increasing number of people develop lipid-associated disorders and metabolic diseases. As such, it is now more important than ever to develop effective strategies to prevent and treat metabolic diseases.

Among other events, increased production of oxidized low-density lipoproteins (oxLDL) is emerging as an important bridge between lipid metabolism dysfunction and development of metabolic diseases. After meals, the liver processes and packages a variety of lipids as LDL particles, which it then sends into the circulation so that these lipids can be delivered to other tissues and organs for their use. In patients with lipid disorders and metabolic diseases, disturbed cell function leads to inflammation and oxidative stress, leading to the modification of a variety of molecules, including the conversion of LDL into oxLDL. Unlike LDL, the uptake of oxLDL by cells leads to further cellular dysfunction, inflammation and oxidative stress, exacerbating a pathogenic vicious cycle that can both trigger and worsen metabolic diseases. Previously, researchers showed that by injecting mice with inactivated S. pneumoniae, a bacterium known for inducing lung and brain disease, they can induce the production of antibodies against phosphorylcholine (PC), a component of S. pneumoniae and of oxLDL. By increasing antibody levels against PC, researchers were able to increase the clearance of oxLDL and improve disease severity in animal models for atherosclerosis, non-alcoholic liver disease and Niemann-Pick disease, suggesting that pneumococcal immunization is a promising tool to target oxLDL.

In order to analyze whether pneumococcal vaccine also increases antibodies against PC and/or oxLDL in humans, we conducted a pilot clinical trial in patients with metabolic diseases characterized by lipid metabolism dysfunction, inflammation and oxidative stress, namely patients with familial hypercholesterolemia, partial lipodystrophy and Niemann-Pick disease. Four weeks after receiving one dose of Prevenar 13, a pneumococcal vaccine commonly used in the clinic, we did not observe an increase in patients’ antibody levels against PC and/or oxLDL. While larger studies are necessary to confirm our findings, our results suggest that a single dose of Prevenar 13 is not suitable to increase antibodies against PC and/or oxLDL. As such, further research is required to develop efficient immunization strategies to target oxLDL in humans.

Ronit Shiri-Sverdlov, Inês Magro dos Reis, Tom Houben
Department of Genetics and Cell Biology, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center, Maastricht, The Netherlands

Publication

The Influence of a Conjugated Pneumococcal Vaccination on Plasma Antibody Levels against Oxidized Low-Density Lipoprotein in Metabolic Disease Patients: A Single-Arm Pilot Clinical Trial
Ronit Shiri-Sverdlov, Inês Magro Dos Reis, Yvonne Oligschlaeger, Tim Hendrikx, Dennis M Meesters, Annick Vanclooster, Nele Vanhoutvin, Ger H Koek, Marit Westerterp, Christoph J Binder, David Cassiman, Tom Houben
Antioxidants (Basel). 2021 Jan 18

Read offline:     

Related Articles:

	Boosting vaccine power: how injection site matters A location of the body surface where a vaccine is administered might be just as important as the vaccine itself. Our research explores how injecting a vaccine at a specific…
	No adverse outcomes for infants associated with mums… What is whooping cough, or pertussis? Whooping cough, or pertussis, is a highly contagious bacterial respiratory infection that can be very serious for young infants. Symptoms include violent coughing fits…
	Rabbits with mammary carcinomas as a model for… Within a breeding colony of rabbits, the American pathologist Harry Greene (1904-1969) observed that mammary carcinomas were restricted to certain families. This is suggestive of a familiar predisposition as it…
	Naturally occurring peptide may tackle the “root… Obesity typically occurs when a person eats more calories than they need for their daily activity. It results in a build-up of fatty tissue around all organs. In lean people,…
	Looking inside the heart: how multiple chronic… The aim of this study was to understand how having several ongoing health problems—what we refer to as multimorbidity—impacts the heart in people with cardiovascular disease, especially those undergoing heart…
	Making Christmas trees under duress, or how cells… Some of the most enduring images for a molecular biologist are electron microscopy micrographs of the so-called “Christmas trees”, famously first observed by Oscar Miller from newt oocytes in 1969.…